C12N 2015/8518
Expressing industrially exogenous proteins
Official title: {expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles}
C12N2015/8518 (Expressing industrially exogenous proteins) appears on 259 US grants and 468 published applications in this corpus.
Search patents in C12N- Granted patents
- 259
- Published applications
- 468
- Assignees
- 218
- Inventors
- 801
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 5 |
| 2010 | 1 | 2 |
| 2011 | 0 | 3 |
| 2012 | 0 | 8 |
| 2013 | 3 | 8 |
| 2014 | 3 | 18 |
| 2015 | 7 | 15 |
| 2016 | 14 | 25 |
| 2017 | 9 | 27 |
| 2018 | 18 | 26 |
| 2019 | 12 | 89 |
| 2020 | 35 | 51 |
| 2021 | 32 | 49 |
| 2022 | 28 | 32 |
| 2023 | 33 | 34 |
| 2024 | 25 | 33 |
| 2025 | 22 | 18 |
| 2026 | 15 | 20 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Antibody conjugates and uses thereof6 Oct 2026US 12,753,242 B2GlycoNex Inc.
- Anti-CD3 antibody and molecules comprising the antibody25 Aug 2026US 12,715,919 B2Daiichi Sankyo Company, Limited
- MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production30 Jun 2026US 12,667,612 B2Fujifilm Biosciences Inc.
- Synthetic antibodies against VEGF and their uses16 Jun 2026US 12,655,202 B2
- Antibody for binding to interleukin 4 receptor14 Apr 2026US 12,600,771 B2Connect Biopharma Hongkong Limited
- Single-sex chicken with toxin-antitoxin system1 Oct 2026US 2026/0293865 A1New York University
- Synthesis and structure of high potency rna therapeutics10 Sep 2026US 2026/0265769 A1Arcturus Therapeutics, Inc.
- Chimeric antigen receptors targeted to psca20 Aug 2026US 2026/0242509 A1City of Hope
- System and method for oral vaccination of animal populations via transgenic insects13 Aug 2026US 2026/0231916 A1Future Fields Cellular Agriculture and Research LTD.
- Antibody for binding to interleukin 4 receptor23 Jul 2026US 2026/0209338 A1Suzhou Connect Biopharmaceuticals, Ltd.
Most cited
By later US patents
- Transgenic transchromosomal rodents for making human antibodies195US 7,041,870 B2Kirin Brewery Co., Ltd. · 2006
- Animal models and therapeutic molecules47US 9,445,581 B2Kymab Limited · 2016
- Transgenic animal for production of antibodies having minimal CDRS42US 8,592,644 B2Crystal Bioscience Inc. · 2013
- Animal models and therapeutic molecules30US 9,253,965 B2Kymab Limited · 2016
- Non-human animals having a humanized signal-regulatory protein gene29US 9,127,292 B2Regeneron Pharmaceuticals, Inc. · 2015